Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adrenaline in Early Sepsis Resuscitation in Children (ANDES CHILD)
NCT06478797Phase 2Not yet recruiting
- Start
- Jul 2024
- Primary completion
- Jul 2025
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, open-label trial of epinephrine in septic shock (2 arms). Primary endpoint: Survival free of organ support at 28 days. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
epinephrine
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT06478797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06478797.